Physician profile
Robert Browning
NPI 1518931831
$72,821.61
in general payments reported to CMS, 2019-2025
8 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42K · 2020: $24K · 2021: $2,500 · 2022: $27.78 · 2023: $3,834 · 2024: $329 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $676 · Travel and Lodging: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $676.31 |
| Travel and Lodging | $659.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csa Medical, INC | $65,940.49 | 2019-2020 | |
| Intuitive Surgical, INC. | $3,676.64 | 2023 | Ion, Da Vinci Surgical System |
| US Endoscopy | $2,500.00 | 2021 | |
| Stryker Corporation | $328.77 | 2024 | Salvation |
| Steris Corporation | $246.70 | 2023-2025 | |
| Noah Medical Corporation | $83.85 | 2025 | Galaxy |
| Mallinckrodt Hospital Products INC. | $27.78 | 2022 | |
| Covidien Lp | $17.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Browning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.